Business Strategy

Our mission is to build a Canada and U.S. based multi-disciplinary primary healthcare service provider of certain high-quality specialized healthcare services and products through the integration of technology and rehabilitative science.

Novo Healthnet Limited ("NHL"), a wholly-owned foreign subsidiary of Novo Integrated Sciences, delivers multi-disciplinary primary healthcare to over 400,000 patients annually through NHL's 16 corporate owned clinics and a contracted network of 88 affiliate clinics and 234 eldercare centric homes located across Canada. NHL's team of practitioners and staff are trained for assessment, diagnosis, treatment, pain management, rehabilitation and primary prevention. Our specialized services and products include physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, chiropody, neurological functions, kinesiology, concussion management and baseline testing, women's pelvic health, sports medicine therapy, assistive devices and private personal training. No employee of the Company or any of its subsidiaries practices primary care medicine and the Company's services do not require a medical or nursing license.

Key elements of our business growth strategy include:

  • Increase Market Share in Canada. We intend to expand our market share in Canada through strategic acquisitions of additional multi-disciplinary primary healthcare providers and clinics in markets that we currently populate as well as new geographic markets. In addition, we expect to continue increasing our market share in existing eldercare services, occupational therapy services, physiotherapy services and speech language pathology services through network affiliation growth and new contract awards.

  • Expand Operations into the United States through:

    • The introduction of a customized version of our multi-disciplinary primary healthcare service model, with emphasis on pain prevention, treatment and management,
    • The strategic acquisition of targeted U.S. operating clinics in key geographical areas, and
    • Establishment of strategic corporate alliances and partnerships with existing U.S.healthcare provider facilities, including certain of our current Canadian clients with U.S. based facilities, allowing us immediate access to their client base; and
    • We expect to integrate specific specialized multi-disciplinary services and products that are a direct compliment to the existing healthcare related products and services already provided by brand-recognized, established retail entities such as grocers, pharmacies and clinics.

  • Leverage our expertise in the interface of technology and patient engagement allows for the introduction of our multi-disciplinary primary healthcare services and products through "micro-clinics" located in underserved population centers. Rather than relying on the traditional centralized model of bringing people to healthcare, our "micro-clinic" model allows for people in urban, rural and remote population centers to have greater access and availability to a wide range of healthcare products and services.

  • Expand our Posture, Stride, and Kinetic Body Movement Scanning Technologies and Protocols. When combined with decades of data harvesting and analysis, we believe these specialized technologies and protocols provide our clinics with the ability to deliver better care, early diagnosis and preventative healthcare strategies.

  • Continue to develop and expand our Virtual Physician Access System. We expect to continue development and expansion of our virtual physician access system, sometimes referred to in the industry as "telemedicine" or "virtual medicine." Our telemedicine system provides patients with real-time access to third-party primary care physicians and specialists in most medical disciplines. Telemedicine is transforming all approaches to healthcare by providing ease of access and reduced costs for patients, particularly in areas with limited access to primary care general practitioners and specialists. Our advanced telemedicine platform integrates certain medical devices, such as a blood pressure reading device, a derma scope and an ophthalmoscope otoscope, each of which can provide the doctor with real-time diagnostic data, greatly enhancing the doctor's ability to provide the patient with an accurate diagnosis. Our telemedicine platform is designed to allow any healthcare clinic or location to install and utilize our telemedicine platform at a relatively low-cost point of entry.

  • Launch our Exclusive Cannabidiol ("CBD") Medical Cannabis Product Platform to include manufacturing, sales and distribution. Our CBD products will be specifically focused on CBD for usage as (i) a treatment aid; (ii) relief for a large array of neurological and musculoskeletal system disorders; and (iii) an alternative option for healthcare providers in place of prescribing opioids to patients. We have established relationships worldwide with low-cost grow and production entities which, when combined with having ownership and control of the end-product manufacturing process, allows us to provide high-quality, low-cost CBD medical products. Offering our patients access to non-hallucinogenic and non-addictive natural remedies, under required clinical oversight policies and procedures as they relate to medicinal cannabis and CBD, combined with our existing clinic-based treatment protocols allows us to enter this market segment with a unique integration model not readily available in the marketplace.

  • Launch our Motor Vehicle Accident ("MVA") service in Canada. Our MVA service is expected to provide certain occupational therapy, assessment, analysis, rehabilitation, mobility aids and counseling.

  • Launch our Independent Medical Evaluation ("IME") service in Canada. Our IME service will be available for corporate and insurance clients.

  • Launch our rehabilitative clinical practice management support program designed to assist purchasers of a proprietary revenue enhancement software franchise.